Affiliation
Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, JapanIssue Date
2016-11
Metadata
Show full item recordAbstract
Cholangiocarcinomas (CC) as well as gallbladder cancers are relatively rare and intractable diseases. Clinical, pathological, and epidemiological studies on these tumors have been under investigation. The current status and/or topics on biliary tract cancers have been reported in the East West Association of Liver Tumor (EWALT), held in Milano, Italy in 2015.Citation
Current status on cholangiocarcinoma and gallbladder cancer. 2016, 6(1):59-65 Liver CancerJournal
Liver CancerDOI
10.1159/000449493PubMed ID
27995089Type
ArticleLanguage
enISSN
2235-1795ae974a485f413a2113503eed53cd6c53
10.1159/000449493
Scopus Count
Collections
Related articles
- Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
- Authors: Huang L, Chen W, Liang P, Hu W, Zhang K, Shen S, Chen J, Zhang Z, Chen B, Han Y, Meng F, DeMorrow S, Yin X, Lai J, Liang L
- Issue date: 2015 May
- Biliary tract cancer.
- Authors: Søreide K, Dopazo C, Berrevoet F, Carrion-Alvarez L, Diaz-Nieto R, Andersson B, Stättner S, joint ESSO-EAHPBA-UEMS core curriculum working group
- Issue date: 2024 Jun 15
- Adjuvant Therapy for Biliary Tract Cancers.
- Authors: Horgan AM, Knox JJ
- Issue date: 2018 Dec
- The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
- Authors: Kirimlioğlu H, Türkmen I, Başsüllü N, Dirican A, Karadağ N, Kirimlioğlu V
- Issue date: 2009 Mar
- Molecular characteristics of biliary tract cancer.
- Authors: Sohal DP, Shrotriya S, Abazeed M, Cruise M, Khorana A
- Issue date: 2016 Nov